Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Dr Reddys Laboratories (RDY) over the last 15 years, with Q3 2025 value amounting to $2.1 billion.

  • Dr Reddys Laboratories' Total Liabilities rose 1024.81% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 1024.81%. This contributed to the annual value of $1.8 billion for FY2025, which is 4213.4% up from last year.
  • As of Q3 2025, Dr Reddys Laboratories' Total Liabilities stood at $2.1 billion, which was up 1024.81% from $1.8 billion recorded in Q1 2025.
  • In the past 5 years, Dr Reddys Laboratories' Total Liabilities registered a high of $2.1 billion during Q3 2025, and its lowest value of $1.1 billion during Q3 2022.
  • In the last 5 years, Dr Reddys Laboratories' Total Liabilities had a median value of $1.3 billion in 2021 and averaged $1.4 billion.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Total Liabilities crashed by 1875.5% in 2023, and later surged by 6461.33% in 2024.
  • Dr Reddys Laboratories' Total Liabilities (Quarter) stood at $1.3 billion in 2021, then decreased by 16.72% to $1.1 billion in 2022, then grew by 6.9% to $1.1 billion in 2023, then surged by 64.61% to $1.9 billion in 2024, then rose by 10.25% to $2.1 billion in 2025.
  • Its last three reported values are $2.1 billion in Q3 2025, $1.8 billion for Q1 2025, and $1.9 billion during Q3 2024.